-
Two human cystic fibrosis (CF) bronchial epithelial cell lines and one CF human primary epithelial cell line in culture were treated with AZM at 10 µg/mL.
-
A retrospective review of pediatric malaria at a Washington, DC, children's hospital identified 98 cases over 8 years (1999-2006). Their mean age was 9.6 years.
-
-
Oude Lashof and colleagues examined the incidence and outcomes of patients with ocular involvement in a randomized, clinical trial comparing treatment of non-neutropenic patients with candidemia with either voriconazole or amphotericin B followed by fluconazole.
-
A 58-year-old Liberian-born woman was in excellent general health, living and working in a large academic medical center in Rhode Island for more than 20 years, when she developed nonspecific gastrointestinal symptoms and underwent endoscopy, which revealed Strongyloides stercoralis larvae on a duodenal biopsy in March 2010.
-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
A total of 130 singleton stillbirths from a single institution in Australia, from January 2005 through December 2006, of > 20 weeks gestation with no cause of death and with available formalin-fixed, paraffin-embedded tissues were examined by multiplex PCR for 19 infectious agents, and by immunohistochemistry for human cytomegalovirus (CMV).
-
The authors conducted a series of experiments in which HIV-1 transfected 1G5 T cells were exposed to either a series of known long terminal repeat (TLR) ligands (FimH/TLR-4, flagellin/TLR-5, and poly I:C/TLR-3) or STI pathogens (HSV-1, HSV-2, and N. gonorrhoeae).
-
As mandatory flu immunization policies continue to gain momentum in health care settings, egg allergy one of the classic exemptions to the vaccine is being redefined by public health officials.
-
Infection preventionists at Vanderbilt Medical Center in Nashville have developed a comprehensive glucometer cleaning protocol that other IPs may want to emulate as regulators respond to outbreaks of hepatitis B virus in diabetics and other patients.
